• Albers D. S. and Beal M. F. (2002) Mitochondrial dysfunction in progressive supranuclear palsy. Neurochem. Int. 40, 559564.
  • Beal M. F. (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 23, 298304.
  • Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K. and Seitelberger F. (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20, 415455.
  • Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 13011306.
  • Caparros-Lefebvre D., Elbaz A. and the Caribbean Parkinsonism Study Group. (1999) Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case–control study. Lancet 354, 281286.
  • Caparros-Lefebvre D., Sergeant N., Lees A., Camuzat A., Daniel S., Lannuzel A., Brice A., Tolosa E., Delacourte A. and Duyckaerts C. (2001) Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain 125, 801811.
  • Cavé A., Figadère B., Laurens A. and Cortes D. (1997) Acetogenins from Annonaceae, in Progress in the Chemistry of Organic Natural Products (HerzW., KirbyG. W. and MooreR. E., eds), pp. 81288. Springer, New York.
  • Degli Espoti M. (1998) Inhibitors of NADH-ubiquinone reductase: an overview. Biochim. Biophys. Acta 1364, 222235.
  • Gobom J., Mueller M., Egelhofer V., Theiss D., Lehrach H. and Nordhoff E. (2002) A calibration method that simplifies and improves accurate determination of peptide molecular masses by MALDI-TOF MS. Anal. Chem. 74, 39153923.
  • Goto K., Mochizuki H., Hattori T., Nakamura N. and Mizuno Y. (1997) Neurotoxic effects of papaverine, tetrahydropapaverine and dimethoxyphenylethylamine on dopaminergic neurons in ventral mesencephalic-striatal co-culture. Brain Res. 754, 260268.
  • Höglinger G., Féger J., Prigent A., Michel P. P., Parain K., Champy P., Ruberg M., Oertel W. H. and Hirsch E. C. (2003) Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 84, 491502.
  • Hudson J. L., Van Horne C. G., Strömberg I., Brock S., Clayton J., Masserano J., Hoffer B. J. and Gerhard G. A. (1993) Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 626, 167174.
  • Koshimura I., Imai H., Hidano T., Endo K., Mochizuki H., Kondo T. and Mizuno Y. (1997) Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system. Brain Res. 773, 108116.
  • Lannuzel A., Michel P. P., Capparos-Lefebvre D., Abaul J., Hocquemiller R. and Ruberg M. (2002) Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe. Movement Disorders 17, 8490.
  • Lannuzel A., Michel P. P., Höglinger G.U. et al. (2003)The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Neuroscience 121, 287296.
  • Oberlies N. H., Croy V. L., Harrison M. L. and McLaughlin J. L. (1997) The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells. Cancer Lett. 115, 7379.
  • Scherfler C., Puschban Z., Ghorayeb I., Goebel G. P., Tison F., Jellinger K., Poewe W. and Wenning G. K. (2000) Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience 99, 4354.